Biorationals Market Size $1.7 Billion by 2030
Report Overview:
The Global Biorationals Market achieved a valuation of $0.9 Billion in 2022 and is anticipated to exceed $1.7 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 9.7% during the forecast period from 2024 to 2032.
Key Market Players:
Koppert B.V. (Netherlands), Bayer AG (Germany), Isagro S.P.A. (Italy), Gowan Company LLC (U.S.), Summit Chemicals Company (U.S.), Suterra LLC (U.S.), Russell IPM (UK), Agralan Ltd. (UK), BASF SE (Germany), Syngenta (Switzerland)
